• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    10/8/24 4:30:55 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology
    Get the next $ICCT alert in real time by email
    SC 13G/A 1 d874376dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

     

    iCoreConnect Inc

    (Name of Issuer)

    Common stock, par value $0.0001 per share

    (Title of Class of Securities)

    450958103

    (CUSIP Number)

    September 27, 2024**

    (Date of Event which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    **

    On September 27, 2024, the Issuer (as defined herein) informed Periscope (as defined herein) of an adjustment to the exercise price of certain convertible securities of the Issuer beneficially owned by Periscope and certain funds advised thereby, resulting in a change in beneficial ownership that triggered the requirement to file this Statement.

     

     

     


    SCHEDULE 13G

    CUSIP No. 450958103

     

     1   

     Names of Reporting Persons

     

     Periscope Capital Inc.

     2  

     Check the appropriate box if a member of a Group (see instructions)

     

     (a) ☐  (b) ☒

     3  

     Sec Use Only

     

     4  

     Citizenship or Place of Organization

     

     Canada

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With:

       5   

     Sole Voting Power

     

      

       6  

     Shared Voting Power

     

     4,082,500

       7  

     Sole Dispositive Power

     

      

       8  

     Shared Dispositive Power

     

     4,082,500

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     4,082,500

    10  

     Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

     

     ☐

    11  

     Percent of class represented by amount in row (9)

     

     28.2% (1)

    12  

     Type of Reporting Person (See Instructions)

     

     FI

     

    (1)

    The percentage set forth in Row 11 of this Cover Page is based on 14,485,336 shares of Common Stock (as defined herein) comprised of 10,404,336 shares of Common Stock outstanding as of August 16, 2024, as reported on the Form 10-Q of the Issuer (as defined herein) filed with the Securities and Exchange Commission on August 16, 2024 plus 4,081,000 shares of Common Stock that would be obtained from the conversion of convertible securities of the Issuer beneficially owned by Periscope (as defined herein) and the Periscope Funds (as defined herein).

     

    Page 2 of 6


    SCHEDULE 13G

    CUSIP No. 450958103

     

     1   

     Names of Reporting Persons

     

     Periscope SPAC Warrant Opportunity Fund LP

     2  

     Check the appropriate box if a member of a Group (see instructions)

     

     (a) ☐  (b) ☒

     3  

     Sec Use Only

     

     4  

     Citizenship or Place of Organization

     

     Canada

    Number of

    Shares  Beneficially 

    Owned by

    Each

    Reporting

    Person

    With:

       5   

     Sole Voting Power

     

      

       6  

     Shared Voting Power

     

     1,762,500

       7  

     Sole Dispositive Power

     

      

       8  

     Shared Dispositive Power

     

     1,762,500

     9   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     1,762,500

    10  

     Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

     

     ☐

    11  

     Percent of class represented by amount in row (9)

     

     12.1% (1)

    12  

     Type of Reporting Person (See Instructions)

     

     PN

     

    (1)

    The percentage set forth in Row 11 of this Cover Page is based on 14,485,336 shares of Common Stock comprised of 10,404,336 shares of Common Stock outstanding as of August 16, 2024, as reported on the Form 10-Q of the Issuer filed with the Securities and Exchange Commission on August 16, 2024 plus 4,081,000 shares of Common Stock that would be obtained from the conversion of convertible securities of the Issuer beneficially owned by Periscope and the Periscope Funds.

     

    Page 3 of 6


    Item 1.

     

    (a)

    Name of Issuer:

    iCoreConnect Inc

     

    (b)

    Address of Issuer’s Principal Executive Offices:

    529 E. Crown Point Road, Suite 250, Ocoee, FL 34761

     

    Item 2.

     

    (a)

    Name of Person Filing:

    This Schedule 13G is being filed on behalf of Periscope Capital Inc. (“Periscope”) and Periscope SPAC Warrant Opportunity Fund LP (“Periscope SPAC WOF”) with respect to the shares of Common stock, par value $0.0001 per share (the “Common Stock”), of iCoreConnect Inc, a Delaware corporation (the “Issuer”).

    Periscope, which is the beneficial owner of 1,905,500 shares of Common Stock on an as-converted basis, acts as investment manager of, and exercises investment discretion with respect to, certain private investment funds, including Periscope SPAC WOF (each, a “Periscope Fund”), that collectively directly own 2,177,000 shares of Common Stock on an as-converted basis.

    The filing of this statement should not be construed as an admission that Periscope is, for the purpose of Section 13 of the Act, the beneficial owner of the Common Stock owned by the Periscope Funds.

     

    (b)

    Address of Principal Business Office or, if None, Residence:

    333 Bay Street, Suite 1240, Toronto, Ontario, Canada M5H 2R2

     

    (c)

    Citizenship:

    See Row 4 of the Cover Page.

     

    (d)

    Title and Class of Securities:

    Common stock, par value $0.0001 per share

     

    (e)

    CUSIP No.:

    450958103

     

    Item 3.

    If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    (a)    ☐    Broker or dealer registered under Section 15 of the Act;
    (b)    ☐    Bank as defined in Section 3(a)(6) of the Act;
    (c)    ☐    Insurance company as defined in Section 3(a)(19) of the Act;
    (d)    ☐    Investment company registered under Section 8 of the Investment Company Act of 1940;
    (e)    ☐    An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
    (f)    ☐    An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
    (g)    ☐    A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
    (h)    ☐    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)    ☐    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
    (j)    ☒    A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);
    (k)    ☐    Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

    If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Non-U.S. investment adviser.

     

    Page 4 of 6


    Item 4.

    Ownership

    The information required by Items 4(a)-(c) is set forth in Rows 5-11 of the Cover Page and is incorporated herein by reference.

    Periscope expressly declares that this filing shall not be construed as an admission that it is, for the purposes of Sections 13(d) or 13(g) of the Act, the beneficial owner of the securities owned by the Periscope Funds.

     

    Item 5.

    Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.

     

    Item 6.

    Ownership of more than Five Percent on Behalf of Another Person.

    Not applicable.

     

    Item 7.

    Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person.

    Not applicable.

     

    Item 8.

    Identification and classification of members of the group.

    Not applicable.

     

    Item 9.

    Notice of Dissolution of Group.

    Not applicable.

     

    Item 10.

    Certifications.

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

    Page 5 of 6


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: October 8, 2024

    PERISCOPE CAPITAL INC.

     

    By:  

    /s/ Lisa Shostack

    Lisa Shostack, General Counsel

    PERISCOPE SPAC WARRANT OPPORTUNITY FUND LP

    By: Periscope Capital Inc., its investment advisor

     

    By:  

    /s/ Lisa Shostack

    Lisa Shostack, General Counsel

    The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

    Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).

     

    Page 6 of 6

    Get the next $ICCT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ICCT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ICCT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Chambers Adam V claimed ownership of 220,289 shares (SEC Form 3)

      3 - iCoreConnect Inc. (0001906133) (Issuer)

      5/13/25 5:25:07 PM ET
      $ICCT
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 3 filed by new insider Liriano Angel

      3 - iCoreConnect Inc. (0001906133) (Issuer)

      5/9/25 5:30:38 PM ET
      $ICCT
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 3 filed by new insider Piedra David

      3 - iCoreConnect Inc. (0001906133) (Issuer)

      5/9/25 5:30:27 PM ET
      $ICCT
      Computer Software: Prepackaged Software
      Technology

    $ICCT
    Leadership Updates

    Live Leadership Updates

    See more
    • The Maryland State Dental Association Expands Endorsement to Include iCoreConnect's Full Platform of Products

      OCOEE, Fla., Nov. 25, 2024 (GLOBE NEWSWIRE) -- iCoreConnect Inc. (NASDAQ:ICCT), a leading provider of cloud-based software and technology solutions, has announced the expansion of its endorsement partnership with the Maryland State Dental Association (as an MSDA Member Perks Endorsed Vendor) to include its full platform of cloud-based software and technology solutions. Before this expansion, the MSDA Member Perks Program endorsed iCoreVerify automated insurance verifications in 2021, followed by iCoreRx cloud ePrescribing in 2022. MSDA's endorsements now include: iCoreVerify - Automated Insurance VerificationsiCoreRx - Cloud ePrescribingiCorePay - Digital Patient Statements, Payments &

      11/25/24 8:30:00 AM ET
      $ICCT
      Computer Software: Prepackaged Software
      Technology
    • iCoreConnect Inc. Announces Strategic Acquisition of Healthcare Circle of Excellence Assets

      OCOEE, Fla., Oct. 03, 2024 (GLOBE NEWSWIRE) -- iCoreConnect Inc. (NASDAQ:ICCT), a prominent cloud-based software and technology provider dedicated to enhancing workflow efficiency and profitability through its enterprise and healthcare platform, today announced the acquisition of substantially all of the assets of the Healthcare Circle of Excellence (HCofE). This acquisition positions iCoreConnect as a leader in providing essential resources and solutions to help local healthcare community partners and practices remain independent and thrive. The strategic move marks a significant expansion of iCoreConnect's partnerships and resources, further enhancing its ability to meet the critical

      10/3/24 8:30:00 AM ET
      $ICCT
      Computer Software: Prepackaged Software
      Technology
    • iCoreConnect Inc. Announces Appointment of Industry Leader Yvonne Hyland to Its Board of Directors

      OCOEE, FL, Sept. 11, 2024 (GLOBE NEWSWIRE) -- iCoreConnect Inc. (NASDAQ:ICCT), a leading cloud-based Software-as-a-Service (SaaS) company specializing in enterprise and healthcare workflow solutions, has announced the appointment of Yvonne Hyland to its Board of Directors. With over 30 years of experience in the global technology industry, Yvonne Hyland has held leadership positions in both startups and Fortune 100 companies. Her impressive career includes key roles at SAP and Gartner, as well as founding and scaling several technology product and service companies, culminating in successful exits. In addition to her entrepreneurial endeavors, Ms. Hyland has also served as a venture ca

      9/11/24 8:30:00 AM ET
      $ICCT
      Computer Software: Prepackaged Software
      Technology